Key facts
- It has raised $148.6M; the latest was Later Stage VC in Nov 2024.
- Notable investors include GV, European Commission, Charles Songhurst, Hawktail, Possible Ventures — 30 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Meatable
- ·The full record, as it builds
Funding rounds
No funding rounds for Meatable are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Meatable
Developer of a stem cell technology designed to manufacture cultured meat. The company's technology eliminates the need to remove any tissue from an animal by using pluripotent stem cells, which possess the ability to turn any type of cell from muscle to fat without serum, enabling consumers to have efficient, sustainable, and delicious food.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Leiden, Netherlands
- Founded
- 2018
- Employees
- 90
- Website
- meatable.com/
- Ownership
- Privately Held (backing)
Meatable doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Meatable shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Meatable in its N-PORT filings yet. We sweep new filings monthly.